Telehealth Anxiety Prescribing: What Psychiatrists Can Do in Pennsylvania

You’re a psychiatric mental health nurse practitioner (PMHNP) with the training to manage anxiety disorders — diagnosing, treating, and prescribing medications. But whether you can actually do that independently depends entirely on where you practice.

Here’s the reality: Yes, PMHNPs can prescribe anxiety medications, including controlled substances like benzodiazepines, in all 50 states. But the conditions under which you can prescribe vary wildly. In New York or Arizona, you can evaluate a patient with panic disorder, start them on an SSRI and a PRN benzodiazepine, and manage their care completely on your own. In Texas or Pennsylvania, you need a physician collaboration agreement just to write that first prescription — and in some states, you might face limits on what you can prescribe or how much.

If you’re exploring telehealth opportunities, considering a move to a new state, or just trying to understand where you stand legally, this guide breaks down the current landscape of PMHNP prescribing authority for anxiety treatment — state by state, medication by medication.

The Three Tiers of PMHNP Practice Authority

The National Council of State Boards of Nursing divides states into three categories when it comes to nurse practitioner scope of practice. For PMHNPs treating anxiety, this framework determines everything from whether you need a supervising psychiatrist to whether you can prescribe controlled substances independently.

Full Practice Authority (FPA) States

In these states, you can practice to the full extent of your education and training without physician oversight. You can:

• Evaluate and diagnose patients independently
• Prescribe all medications, including controlled substances
• Open your own practice without a collaborating physician
• Manage patient care from intake through discharge

Key FPA states as of 2026: New York (since 2022), Oregon, Washington, Arizona, Alaska, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Rhode Island, South Dakota, Vermont, Wyoming, and the District of Columbia.

New York’s recent change: In April 2022, Governor Hochul signed legislation granting PMHNPs full independence, eliminating the previous 3,600-hour collaborative agreement requirement. If you’re a New York PMHNP, you can now manage anxiety patients — prescribing SSRIs, SNRIs, benzodiazepines, whatever’s clinically appropriate — without any physician involvement.

Reduced Practice States

These states require a career-long collaborative agreement or supervisory relationship with a physician for prescriptive authority. You can diagnose and treat, but prescribing requires physician authorization (though not necessarily real-time oversight).

Key reduced practice states: Florida, Texas, Pennsylvania, and many others fall into this category, though some (like California and Illinois) are transitioning toward independence for experienced providers.

Restricted Practice States

In these states, nurse practitioners need direct physician supervision for most or all practice activities, including diagnosing and prescribing. These are the most limiting environments for PMHNP practice, though even here, you can prescribe anxiety medications if your supervising physician delegates that authority.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Breakdown: Where PMHNPs Stand on Anxiety Prescribing

Let’s get specific. If you’re licensed (or considering licensure) in one of these high-demand states, here’s exactly what you can and can’t do when it comes to managing anxiety with medications.

California: Mid-Transition to Independence

Current Status: Historically one of the most restrictive states, California is in the middle of a major shift thanks to AB 890 (enacted in 2020).

The Old Rules (pre-2023): California PMHNPs needed a supervising physician and written ‘standardized procedures’ to prescribe anything — even a basic SSRI for generalized anxiety disorder. You couldn’t prescribe outside the scope of those written protocols, which meant less autonomy than almost any other state.

The New Rules (2023-2026):

• As of January 2023, experienced NPs can become 103 NPs — practicing without standardized procedures in group settings that include at least one physician
• Starting January 2026, NPs who’ve maintained 3 years of good practice as a 103 NP can become 104 NPs — allowing full independent practice, including solo telehealth

What this means for anxiety prescribing: If you’re an established California PMHNP with the required experience, you can now manage anxiety treatment independently — starting patients on escitalopram, adjusting sertraline doses, prescribing clonazepam for panic disorder, all without physician protocols. If you’re newly graduated, you’ll still need those standardized procedures and physician oversight until you qualify for 103/104 status.

Controlled substances: California already allowed PMHNPs to prescribe Schedule II-V controlled substances if they had a DEA number and physician protocol. AB 890 didn’t change the medication formulary — it just removed the protocol requirement for experienced providers.

The catch: You need to complete the certification process and meet the experience thresholds. The California Board of Registered Nursing started accepting 104 NP applications in early 2026.

Texas: Collaboration Required, Schedule II Restricted

Current Status: Texas remains one of the more restrictive states for PMHNP practice.

Collaboration requirement: Every Texas PMHNP must maintain a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe any medication. The physician doesn’t co-sign every prescription, but they must be available for consultation and conduct periodic chart reviews.

Schedule II limitations: Here’s where it gets tricky for anxiety management. Texas law prohibits NPs and PAs from prescribing Schedule II controlled substances in outpatient settings, with very limited exceptions:

• Hospital-based practices (patients admitted ≥24 hours or in the ER)
• Hospice or terminally ill patients
• Under direct physician supervision in certain institutional settings

What this means practically:

• SSRIs, SNRIs, buspirone, hydroxyzine — you can prescribe these freely under your agreement
• Benzodiazepines (Schedule IV) like alprazolam, lorazepam, clonazepam — you can prescribe if your collaborating physician has authorized it in your agreement and you have a DEA registration
• Schedule II stimulants (sometimes used for treatment-resistant anxiety or comorbid ADHD) — you generally cannot prescribe these in an outpatient telehealth setting

Physician supervision ratio: One Texas physician can supervise at most 7 advanced practice nurses for prescribing purposes.

The bottom line: You can manage most anxiety cases effectively in Texas, but you’ll always need that physician collaboration, and certain high-stakes or complex cases requiring Schedule II medications will need physician involvement.

Florida: Protocol-Based Practice with Psychiatric Exceptions

Current Status: Florida created a pathway to NP independence in 2020, but it explicitly excluded psychiatric nurse practitioners.

Collaboration requirement: PMHNPs must practice under a written protocol with a physician. The protocol outlines which conditions you can treat and which medications you can prescribe. The supervising physician doesn’t see every patient but must review and approve your protocols.

Controlled substance rules — and the psychiatric carve-out:Florida law limits NPs to a 7-day supply of Schedule II-IV controlled substances… unless you’re a psychiatric NP prescribing psychiatric medications for a mental health disorder.

This exception is huge. It means:

• You can prescribe a month’s supply of alprazolam for panic disorder (not just 7 days)
• You can manage ongoing benzodiazepine treatment for anxiety without the arbitrary supply limits that apply to other NP specialties
• For comorbid ADHD, you can prescribe Schedule II stimulants for longer than 7 days if you’re treating the psychiatric condition

Requirements: To prescribe controlled substances in Florida, you need additional training, Board approval, and a DEA license.

What this means for telehealth: If you’re a Florida-licensed PMHNP working on a platform like Klarity, you can manage anxiety patients effectively — including benzodiazepine prescribing — as long as your protocol supports it and your supervising physician is on board. Just note that if you’re licensed outside Florida and practicing via Florida’s out-of-state telehealth registration, you cannot prescribe controlled substances to Florida patients remotely.

New York: Full Independence for All PMHNPs

Current Status: New York is now one of the most PMHNP-friendly states in the country.

The 2022 change: Governor Hochul signed the Nurse Practitioner Modernization Act, granting full practice authority to all New York NPs. No written practice agreement required. No collaborative relationship mandate. No experience threshold to meet.

What you can do:

• Open your own psychiatric practice
• Evaluate, diagnose, and treat anxiety disorders independently
• Prescribe any medication in your scope — SSRIs, benzodiazepines, any controlled substance
• Practice via telehealth without physician oversight

The only requirement: You must check New York’s PDMP (iSTOP) before prescribing any controlled substance. New York has one of the strictest prescription monitoring programs — you’re required to query it for every controlled medication prescription, including benzodiazepines for anxiety.

Reimbursement note: Medicare pays PMHNPs at 85% of the physician fee schedule. Some private insurers in New York have pay parity, others don’t — but the gap is narrowing as demand for mental health services outpaces psychiatrist supply.

Pennsylvania: Collaboration with Chart Review Requirements

Current Status: Pennsylvania remains a restricted practice state with no recent movement toward independence.

Collaboration requirement: PMHNPs must have a written collaborative agreement with a physician. The agreement must specify:

• Which categories of drugs you can prescribe
• Chart review requirements (typically 10% of all charts, 100% of charts involving Schedule II prescriptions within 24 hours)
• Consultation protocols

Controlled substances: You can prescribe benzodiazepines and other anxiety medications if they’re authorized in your collaborative agreement. For Schedule II medications (like stimulants for comorbid ADHD), your collaborating physician must review those charts within 24 hours and may need to co-sign.

Physician oversight ratio: Pennsylvania physicians can collaborate with up to 4 NPs.

The ongoing legislative battle: Bills to grant PMHNPs full practice authority have been introduced repeatedly in the Pennsylvania legislature but haven’t passed as of 2026. The state faces significant mental health provider shortages (only 31% of need met in rural areas), but physician groups have successfully blocked scope expansion so far.

Practical impact: For anxiety management on a telehealth platform, you’ll need a Pennsylvania-licensed physician willing to serve as your collaborator. Many platforms handle this by employing psychiatrists who can oversee multiple PMHNPs, but it’s an added layer of complexity that doesn’t exist in FPA states.

Illinois: Pathway to Independence After 4,000 Hours

Current Status: Illinois offers a hybrid model — collaboration required initially, independence available after experience.

The pathway:

• New PMHNPs: Must have a collaborative agreement with a physician for prescribing
• Experienced PMHNPs: After completing 4,000 hours of clinical practice and 250 hours of continuing education post-graduation, you can apply for Full Practice Authority

Controlled substances caveat: Even PMHNPs with full practice authority need a physician consultation agreement for prescribing benzodiazepines or Schedule II narcotics. This isn’t ongoing supervision — it’s a one-time physician attestation that you’ll be prescribing these medication classes. After that sign-off, you can prescribe independently.

What this means: If you’re an established Illinois PMHNP, you’ve likely already obtained FPA status and can manage anxiety treatment autonomously (with that initial controlled substance consultation on file). If you’re newly graduated, you’ll work under collaboration for your first few years, then transition to independence.

Additional requirement: Illinois requires a separate state controlled substance license in addition to your DEA registration.

The Federal Layer: Telehealth Prescribing of Controlled Substances

State laws determine whether you can prescribe independently, but federal law determines how you can prescribe controlled substances via telehealth.

The Ryan Haight Act and COVID-Era Flexibilities

Historically, the Ryan Haight Act required at least one in-person medical evaluation before prescribing controlled substances. This created a major barrier for telehealth psychiatry — you couldn’t start a patient on clonazepam for panic disorder without seeing them face-to-face first.

COVID changed everything. In March 2020, the DEA suspended this requirement through a series of temporary rules, allowing providers to prescribe controlled substances (including benzodiazepines, stimulants, and other anxiety medications) via telehealth without prior in-person visits.

Current status (2026): These flexibilities have been extended through December 2026. As of early 2026, you can:

• Conduct an initial psychiatric evaluation via video
• Prescribe benzodiazepines for anxiety without an in-person visit
• Manage ongoing controlled substance treatment entirely through telehealth

What’s coming: The DEA and HHS are working on permanent telemedicine prescribing regulations expected in late 2026. The likely outcome is a special telemedicine prescribing registration or modified evaluation standards — but for now, the COVID-era rules remain in effect.

The numbers: In 2024 alone, over 7 million controlled substance prescriptions (for ADHD, anxiety, and other conditions) were written via telemedicine without in-person encounters. Regulators recognize that abruptly ending these flexibilities would cut off access for millions of patients.

State-Specific Telehealth Rules

While federal law allows broad telemedicine prescribing through 2026, some states add extra requirements:

Florida: Explicitly permits telehealth prescribing of Schedule II drugs for psychiatric disorders (other medical specialties face restrictions). Mandatory PDMP check required.

Texas: Requires a valid patient-practitioner relationship established via live audio-visual exam. Prohibits telemedicine treatment of chronic pain with controlled substances, but anxiety treatment is permitted. PDMP check required.

California, New York, Pennsylvania, Illinois: No special state-level restrictions beyond federal rules. Standard of care and PDMP requirements apply.

What Medications Can PMHNPs Prescribe for Anxiety?

Let’s get specific about the medication classes you’ll use most often in anxiety management and any prescribing restrictions.

First-Line Treatments (No Restrictions)

SSRIs and SNRIs: These are the backbone of anxiety treatment, and every PMHNP in every state can prescribe them (with or without collaboration, depending on your state):

• Sertraline (Zoloft)
• Escitalopram (Lexapro)
• Paroxetine (Paxil)
• Fluoxetine (Prozac)
• Venlafaxine (Effexor)
• Duloxetine (Cymbalta)

Other non-controlled options:

• Buspirone (Buspar) — often preferred in states with restrictive controlled substance policies
• Hydroxyzine (Vistaril) — useful for acute anxiety, not controlled
• Beta-blockers (propranolol) for performance anxiety
• Gabapentin — increasingly used for anxiety, not scheduled federally (though some states like Kentucky have scheduled it)

Benzodiazepines (Schedule IV — State-Dependent)

Medications:

• Alprazolam (Xanax)
• Lorazepam (Ativan)
• Clonazepam (Klonopin)
• Diazepam (Valium)

PMHNP prescribing authority:

• FPA states (NY, AZ, OR, etc.): You can prescribe independently with your DEA registration
• Reduced/restricted states: You can prescribe if your collaborative agreement authorizes it and you have DEA registration
• Florida: No 7-day limit for psychiatric NPs treating mental health conditions (unlike other NP specialties)
• Texas: Can prescribe under physician delegation (Schedule IV has fewer restrictions than Schedule II)

Federal requirement (all states): You need a DEA registration. Most states require PDMP checks before prescribing.

Schedule II Stimulants (Highly Restricted for NPs)

Why this matters for anxiety: While stimulants aren’t first-line for anxiety, they’re sometimes used for:

• Comorbid ADHD with anxiety
• Treatment-resistant depression with anxiety
• Atypical presentations

Medications:

• Amphetamine/dextroamphetamine (Adderall)
• Methylphenidate (Ritalin, Concerta)
• Lisdexamfetamine (Vyvanse)

PMHNP restrictions:

• Texas: Cannot prescribe in outpatient settings (hospital/hospice only)
• Florida: 7-day limit unless you’re a psychiatric NP treating a psychiatric disorder
• Pennsylvania: Physician must co-sign within 24 hours
• FPA states: Generally can prescribe independently, but some states (like Illinois) require that initial physician consultation for Schedule II

Practical impact: For most anxiety-focused telehealth work, this won’t affect you — but if you’re managing complex cases with comorbidities, know your state’s Schedule II restrictions.

PMHNP vs. Psychiatrist: Where Authority Differs

The training gap is real — psychiatrists complete 4 years of medical school plus 4 years of residency (8+ years post-college), while PMHNPs typically complete 2-3 years of graduate training. But when it comes to prescribing authority for anxiety, the differences are entirely legal, not clinical.

What Psychiatrists Can Do Everywhere

• Practice independently in all 50 states
• Prescribe any medication without physician oversight
• No restrictions on Schedule II prescribing
• No collaborative agreement requirements for telehealth

Where PMHNPs Face Restrictions

• 22 states still require physician collaboration or supervision
• Schedule II prescribing limited or prohibited in several states
• Reimbursement — Medicare pays PMHNPs at 85% of physician rates
• Telehealth complexity — in restricted states, you need a local physician collaborator even for remote practice

Where PMHNPs Have Parity

• Full practice authority states — complete prescribing autonomy
• Clinical outcomes — research shows PMHNPs provide effective medication management for anxiety and depression with similar patient outcomes to psychiatrists for routine cases
• Scope of practice — in your specialty area (anxiety, depression, common psychiatric conditions), there’s no clinical skill difference once you’re practicing independently

The Economic Reality

The PMHNP vs. psychiatrist debate often comes down to economics and access:

• Psychiatrist shortage: National ratio is roughly 1 psychiatrist per 5,000 people. States like Texas (1:8,966) and Florida (1:8,577) face severe shortages.
• PMHNP workforce: Growing rapidly, with many providers filling gaps in underserved areas
• Cost-effectiveness: PMHNPs typically command lower salaries than psychiatrists ($120K-$140K vs. $250K-$300K), making them attractive for telehealth platforms managing large patient volumes

The reality is that patients with anxiety disorders need someone who can prescribe effective treatment. In states with severe psychiatrist shortages, restricting PMHNP practice authority just means patients wait longer for care — or don’t get it at all.

Why This Matters for Telehealth Providers

If you’re considering joining a telehealth platform to treat anxiety patients, your state’s practice authority directly impacts:

1. Which States You Can Practice In

FPA states: You can join a platform and start seeing patients immediately (after obtaining that state’s license). No need to find a collaborating physician in that state.

Restricted states: The platform needs to either:

• Employ psychiatrists who can serve as your collaborators
• Partner with local physicians willing to oversee NP prescribing
• Limit your practice to non-controlled medications (which severely limits anxiety treatment)

2. What You Can Prescribe

Example scenario: A patient in Texas contacts you via telehealth with panic disorder and comorbid ADHD.

• If you’re a Texas-licensed PMHNP: You can manage the panic disorder with an SSRI and benzodiazepine (under your collaborative agreement), but you cannot prescribe the Adderall for ADHD. That patient would need to see a psychiatrist or physician on the platform.

• If you’re a New York-licensed PMHNP treating a New York patient: You can manage the entire case — SSRI, benzodiazepine, and stimulant — completely independently.

3. Reimbursement and Economics

Medicare patients: You’ll be reimbursed at 85% of physician rates. For a 15-minute medication management visit (99213), that’s about $81 versus $95 for a psychiatrist.

Commercial insurance: Some private payers have pay parity for NPs, others pay 85-90% of physician rates.

Cash-pay models: Some platforms use subscription or direct-pay models where this doesn’t matter.

The platform’s perspective: Klarity and similar companies can see more patients per dollar by employing PMHNPs in states where you have full authority. In restricted states, the administrative burden of maintaining physician collaborations and the prescribing limitations make NP employment less attractive — which is why many platforms focus recruitment on FPA states or ensure they have psychiatrist coverage in restricted states.

4. Patient Acquisition Cost

Here’s where platforms like Klarity create real value for providers. Let’s talk about what it actually costs to acquire psychiatric patients through traditional marketing:

DIY Marketing Reality:

• Google Ads for mental health keywords: $15-40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient through PPC: $200-400+
• SEO investment: 6-12 months of consistent content, backlinks, and optimization before generating meaningful patient flow. Most solo providers don’t have this expertise or patience.
• Directory listings: Psychology Today charges monthly fees and you’re competing with hundreds of providers on the same page. Zocdoc charges per booking ($35-100+) plus monthly subscription fees.
• Total all-in CAC: When you factor in agency/consultant fees, ad spend testing, staff time to qualify leads, no-show rates from cold leads, and failed campaigns, acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+

The Klarity Model:Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. This is a pay-per-appointment model similar to Zocdoc — a standard listing fee per new patient lead.

Why this matters:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

This is guaranteed ROI versus gambling on marketing channels. DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience — but for most providers (especially those starting out or scaling), a platform that handles patient acquisition removes the risk entirely.

FAQ: PMHNP Anxiety Prescribing

Can a psychiatric nurse practitioner prescribe Xanax?

Yes, in all 50 states — but the conditions vary. In full practice authority states (New York, Arizona, Oregon, etc.), you can prescribe alprazolam independently with your DEA registration. In restricted states (Texas, Pennsylvania, Florida), you need a collaborative agreement with a physician that authorizes controlled substance prescribing. Florida psychiatric NPs have an advantage: no 7-day supply limit when treating mental health conditions.

Do I need a collaborating physician to prescribe anxiety medications as a PMHNP?

It depends on your state:

• No collaboration needed: New York, Arizona, Oregon, Washington, Alaska, Connecticut, Hawaii, Idaho, Iowa, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Rhode Island, South Dakota, Vermont, Wyoming, DC
• Collaboration required: Texas, Pennsylvania, Florida, and most other states
• Pathway to independence: California (via 103/104 NP certification), Illinois (after 4,000 hours + 250 CE hours)

Can PMHNPs prescribe controlled substances via telehealth?

Yes, through December 2026 under extended federal COVID-era flexibilities. You can conduct initial evaluations via video and prescribe benzodiazepines or other controlled anxiety medications without an in-person visit. State laws still apply — you must be licensed in the patient’s state and follow that state’s PMHNP practice authority rules. Permanent federal regulations are expected in late 2026.

What’s the difference between PMHNP and psychiatrist prescribing authority?

Psychiatrists (MD/DO): Independent prescribing in all states. No restrictions on medication classes or controlled substances. No collaboration requirements.

PMHNPs: Prescribing authority varies by state. In FPA states, essentially identical to psychiatrists for anxiety treatment. In restricted states, require physician collaboration and may face Schedule II limitations.

Clinical capability: For routine anxiety management (SSRIs, SNRIs, benzodiazepines), there’s no practical difference in states where PMHNPs have full authority.

Can I prescribe benzodiazepines as a new graduate PMHNP?

If you’re in a full practice authority state, yes — you can prescribe benzodiazepines independently as soon as you obtain your state license and DEA registration.

If you’re in a restricted state, you need a collaborative agreement with a physician first. That physician must explicitly authorize controlled substance prescribing in your agreement. In some states (like Illinois), you’ll also need that physician to sign off on your controlled substance authority even after you obtain full practice status.

How does PMHNP reimbursement compare to psychiatrists for medication management?

Medicare: PMHNPs are reimbursed at 85% of the physician fee schedule. For a 15-minute medication management visit (99213), that’s approximately $81 for an NP versus $95 for a psychiatrist in 2026.

Medicaid: Varies by state. Some states pay NPs the same as physicians; others pay 85-95% of physician rates.

Commercial insurance: Most private insurers pay PMHNPs at 85-90% of physician rates, though some states have mandated pay parity.

Telehealth parity: Most states require insurers to reimburse telehealth visits at the same rate as in-person for mental health services.

The Bottom Line: Know Your State, Know Your Options

If you’re a PMHNP, your ability to treat anxiety independently — and the economic opportunity that creates — depends entirely on where you practice.

Best states for PMHNP anxiety prescribers:

• New York: Full independence since 2022, strong telehealth infrastructure, high patient demand
• Arizona, Oregon, Washington: Long-standing FPA, robust telehealth markets
• California: Becoming FPA-friendly for experienced providers (103/104 pathway)
• Illinois: Clear pathway to independence after 4,000 hours

Most restrictive states:

• Texas: Mandatory physician collaboration, Schedule II prohibition in outpatient settings
• Pennsylvania: Career-long collaboration requirement, no legislative movement toward independence
• Florida: Written protocols required, though psychiatric NPs get better controlled substance authority than other specialties

For telehealth practice: FPA states offer the most straightforward path. In restricted states, platforms need physician infrastructure to support NP prescribing — which adds complexity and may limit your patient volume or compensation.

The opportunity: Mental health provider shortages mean demand far exceeds supply. Whether you’re in Texas (1:8,966 psychiatrist-to-patient ratio) or New York (1:2,913), patients need anxiety treatment. Platforms like Klarity remove the marketing risk and patient acquisition burden, letting you focus on clinical care while handling the business infrastructure and compliance requirements specific to each state.

The question isn’t whether PMHNPs should be able to prescribe anxiety medications independently — the clinical evidence supports it, and the access crisis demands it. The question is whether your state’s laws allow you to practice to the full extent of your training. Know those laws, position yourself accordingly, and choose practice opportunities that maximize your autonomy and impact.

Sources and References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov) – Official government source on federal telehealth prescribing policy, Jan 2, 2026

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov) – State law text defining NP scope and telehealth rules in Florida, 2024 Statutes

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov) – State regulatory guidance on new NP independent practice categories, Updated 2024

4. NPNY announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com) – NY NP association documentation of practice authority changes, April 9, 2022

5. NursePractitionerLicense.com – Illinois NP Licensure & Limitations – Educational resource citing Illinois state law for NP practice authority, Updated Feb 12, 2024

6. Texas Medical Board FAQ – NP prescribing of Schedule II (tmb.state.tx.us) – State board guidance on physician delegation limits for controlled substances, Current 2026

7. Little Health Law Blog – ‘Texas Telemedicine Prescribing Rules’ – Legal analysis of Texas telemedicine regulations citing state statutes, Aug 29, 2022

8. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com) – Industry analysis aggregating CMS data for psychiatric billing, 2025 (rates for 2026)

9. Healing Psychiatry Florida – ‘Psychiatrist Shortage by State – 2026 Report’ – Analysis of HPSA and workforce data for provider supply context, Jan 15, 2026

10. MedX ‘Prescribing Authority – Can NPs prescribe Anxiety Meds?’ (medx.it.com) – Healthcare education resource explaining NP scope categories, Nov 9, 2025

11. Axios News – ‘COVID-era telehealth prescribing extended again’ – News coverage of DEA 2024 extension rule, Nov 18, 2024

12. SAMHSA Announcement – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (samhsa.gov) – Government agency confirmation of federal policy extension, Nov 15, 2024

13. Zivian Health – ‘NP-Physician Collaboration Regulations: 2026 Roadmap’ (zivianhealth.com) – Industry overview of multi-state collaboration laws, Feb 16, 2026

14. AMA Advocacy Update – ‘New rules issued for telemedicine prescribing’ (ama-assn.org) – Professional organization coverage of DEA proposed rules, Jan 24, 2025

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs